KLK-L14 (AA 239-251) antibody
-
- Target
- KLK-L14
- Binding Specificity
- AA 239-251
- Reactivity
- Human
- Host
- Rabbit
- Clonality
- Polyclonal
- Application
- Western Blotting (WB)
- Purification
- Affinity chromatography purified
- Immunogen
- KLK-L14 antibody was raised in rabbit using AA 239-251 [KYRSWIEETMRDK] of the 27 kDa human KLK14 protein as the immunogen.
- Isotype
- IgG
-
- Application Notes
-
WB: 1:500-1:1,000
Optimal conditions should be determined by the investigator. - Restrictions
- For Research Use only
-
- Concentration
- Lot specific
- Buffer
- Affinity purified IgG supplied in PBS with 0.02 % NaN3.
- Preservative
- Sodium azide
- Precaution of Use
- This product contains Sodium Azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Handling Advice
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. - Storage
- 4 °C/-20 °C
- Storage Comment
- Store at 4 °C for short term storage. Aliquot and store at -20 °C for long term storage.
-
- Target
- KLK-L14
- Background
- Kallikreins are a subgroup of serine proteases and are implicated in carcinogenesis. The novel KLK gene, KLK14 (also knows as KLK-L14 and KLK-L6) is expressed by both benign and malignant glandular epithelial cells, thus exhibiting an expression pattern similar to that of two other prostatic kallikreins, KLK2 and KLK3.
-